Title	Published	Price
Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 - Future Therapies for Birth Control and Reproductive Health By: Spectra Intelligence ... Contraceptives and Infertility Drugs, 2011-2018 - Future Therapies for Birth Control and Reproductive Health (2nd Edition) the reader will be introduced to an analysis of current product markets, research and development themes, and company activities ... \| more... Search inside this report	5/25/2011	$2,815.00
The World Market for Addiction Disorders, 2009 - 2016 By: Spectra Intelligence ... for alcohol, narcotic, and nicotine dependencies are poised to radically change the addiction treatment landscape in this difficult-to-treat patient population. The report estimates that the current market for addiction disorders is valued at US$3.2 billion ... \| more... Search inside this report	10/1/2009	$2,345.00
Indian Generics, 2008-2012: The Growing Threat to Westernised Markets By: Spectra Intelligence ... have applied themselves to the challenge of entering Western markets with great success. These companies now present a very serious threat to the existing Western generic companies in their domestic markets as they take ever-larger ... \| more... Search inside this report	1/1/2008	$2,400.00
The World Market for Gynaecology, 2007-2017 By: Spectra Intelligence ... by one of the top three multinational pharmaceutical companies presents a detailed and comprehensive analysis of prescription products used in the diverse areas of infertility, contraception, gynaecological disorders, and menopause. The market for gynaecology is ... \| more... Search inside this report	9/1/2007	$4,800.00
Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success By: Spectra Intelligence ... on preclinical scientific studies and expert opinion. In the report, analysts decode the necessary parameters of market success for novel and next-generation drug targets. Through their diligent market research and academic insight, founded on years ... \| more... Search inside this report	12/1/2006	$2,400.00
The Global Market for Antimicrobials and Antifungals: Challenging Resistance to 2016 By: Spectra Intelligence ... between US$15 and US$20 billion by 2016. This forecast is based on a number of factors, but largely due to declining rates of antibiotic prescriptions for respiratory infections - a major segment of the market. ... \| more... Search inside this report	12/1/2006	$2,400.00
Pharmaceutical Parallel Trade in the United Kingdom, 2000-2006: Market Insights and Trends in a Primary Import Destination By: Spectra Intelligence ... £1 billion (US$1.8 billion). Importing drugs into the UK is highly attractive for several reasons: The relatively high prices of domestically supplied drugs compared with European counterparts Government incentives encouraging pharmacists to source and dispense ... \| more... Search inside this report	8/1/2006	$1,350.00
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines and Commercial Opportunities By: Spectra Intelligence ... introduction of new oncology drugs with great therapeutic and market potential over the next decade. The oncology market is currently the fastest growing in the pharmaceutical industry, driven by the explosion of potential therapeutic targets ... \| more...	4/1/2006	$2,850.00
Antiageing and Life Enhancement Pharmacotherapeutics: Rejuvenating Drug Markets to 2012 and Beyond - Volume Edition By: Spectra Intelligence ... medical attention to restore, alter, or improve undesired aspects of body image, physical function, or wellbeing. The conditions are wide-ranging and comprise the four major medical specialty areas of dermatology, psychiatry, reproductive health and sexual ... \| more...	1/26/2006	$6,900.00
The World Market for Sexual Disorders, 2005-2012: Traversing New Frontiers in Sexual Chemistry By: Spectra Intelligence ... of R&D programs within the field is also highlighted showing products from preclinical to premarket authorization phases of development, with promising agents further discussed from commercial and drug development perspectives. Therapy area forecasting and illustrative ... \| more... Search inside this report	1/20/2006	$2,850.00
The Global Market for Sleep-Wake Disorders, 2005-2012 Trends, Opportunities, and Insights in a High-Value CNS Therapy Area By: Spectra Intelligence ... global market estimated at US$4.3 billion and forecast to increase 158% to US$11 billion by 2012, drugs for sleep-wake disorders such as insomnia, excessive daytime sleepiness, shift-work sleep disorder, sleep apnoea, and restless legs syndrome ... \| more... Search inside this report	12/9/2005	$1,650.00
The Global Image Dermatology Drug Market, 2005-2012: High-Growth Opportunities in Aesthetic Medicine By: Spectra Intelligence ... associated with cutaneous ageing, photodamage, pigmentation defects, alopecia, and the lipodermal disorders of obesity and gynoid lipodystrophy are critically discussed to provide a detailed analysis of the high-growth market sector estimated at US$1.8 billion in ... \| more... Search inside this report	11/1/2005	$2,850.00
Psychopharmacotherapy Market Insights: Obstacles and Opportunities in Mood Disorders and Cognitive Impairment, 2005-2012 By: Spectra Intelligence ... discussed include patent expirations of leading antidepressants over the next 7 years, increased generic substitution trends, safety concerns over SSRIs; cost-containment in prescribing; and litigation activities between research-based and generic companies. Key market stimulators identified ... \| more... Search inside this report	11/1/2005	$2,850.00
Title	Published	Price

Title Index: # | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

MarketResearch.com

Our People

On The Web

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: Monday - Thursday: 5:30am - 7:00pm EST

Fridays: 5:30am - 6:00pm EST